Clinical Oncology Annual Meeting

Related by string. * clinicals . CLINICAL . Clinicals : Phase III clinical trials . Phase III clinical . placebo controlled clinical trials / ONCOLOGY . oncology : Radiation Oncology ASTRO . pediatric oncology . oncology virology inflammation / annuals . annual . Annuals : Annual Screen Actors . MOST RECENTLY FILED ANNUAL . Annual Shareholder Meeting / meeting . Meets : General Meeting . Town Meeting * *

Related by context. All words. (Click for frequent words.) 89 Hematology Annual Meeting 87 Clinical Oncology ASCO Annual 86 Hematology ASH Annual Meeting 86 Hematology Meeting 82 Nephrology Renal Week 82 Hematology ASH 81 Cancers Symposium 81 Clinical Oncology ASCO 79 Hematology ASH Meeting 78 Clinical Oncologists 76 Clinical Oncology ASCO Gastrointestinal 76 nd Annual Meeting 76 Gene Therapy ASGT 76 Medical Oncology ESMO 75 Connective Tissue Oncology 75 ASCO Annual Meeting 75 Radiation Oncology ASTRO 74 Clinical Oncology Gastrointestinal Cancers 74 Annual Scientific Sessions 74 st Annual Meeting 74 Gastrointestinal Cancers Symposium 74 ASH Annual Meeting 73 Breast Surgeons ASBS 73 Anesthesiologists Annual Meeting 73 Cancer iSBTc 72 Retina Specialists 72 Clinical Oncology 72 Genitourinary Cancers Symposium 72 Hypertension ASH 72 Nephrology Annual Meeting 72 Cardiology ESC Congress 71 Microbiology ASM 71 Mass Spectrometry ASMS 71 Anesthesiologists ASA Annual Meeting 71 Neurology Annual Meeting 71 AACR #st Annual Meeting 71 AACR #nd Annual Meeting 71 Digestive Disease Week DDW 71 Neuro Oncology SNO 70 Biological Therapy 70 ASCO GI 70 Human Genetics ASHG 70 AHA Scientific Sessions 70 AACR San Antonio 70 Therapeutic Radiology 70 American Roentgen Ray 70 Oncology ASTRO 69 AUA Annual Meeting 69 #st Annual Meeting 69 Rheumatology ACR Annual 69 Interventional Radiology SIR 69 Nephrology ASN Renal 69 Society CTOS 69 Hematology 69 Therapeutic Radiation 69 ADA Scientific Sessions 69 Pharmaceutical Scientists AAPS 68 Digestive Disease Week 68 Neurology AAN 68 Breast Surgeons 68 Hypertension ESH 68 Cell Biology ASCB 68 Gynecologic Oncologists 68 Scientific Session 68 AACR NCI EORTC 68 Cellular Therapy ISCT 68 Retina Specialists ASRS 68 Stem Cell Research ISSCR 67 System Pharmacists ASHP 67 Scientific Sessions 67 #nd Annual Meeting 67 Late Breaker 67 Gynecologic Investigation 67 EORTC NCI AACR 67 AACR Annual Meeting 67 Therapeutics TCT scientific 66 Clinical Oncologists ASCO 66 ICAAC 66 EORTC NCI AACR Symposium 66 Mineral Research ASBMR 66 Anesthesiologists ASA 66 CTRC AACR San Antonio 66 Echocardiography ASE 66 Cardiovascular Anesthesiologists 66 Surgical Oncology SSO 66 Liver Diseases AASLD 66 Reproductive Medicine ASRM 66 Scientific Meeting 66 AAN Annual Meeting 66 ECTRIMS 65 annual Transcatheter Cardiovascular 65 Arteriosclerosis Thrombosis 65 Cardiology ESC 65 #th Annual Interscience 65 Liver EASL 65 Nephrology JASN 65 EORTC NCI 65 Controlled Release 65 ISPOR 65 ASCO Genitourinary Cancers Symposium 65 Chemotherapy ICAAC 64 Endoscopic Surgeons 64 ICAAC IDSA 64 Digestive Diseases Week 64 League Against Rheumatism 64 ongoing Phase 1b 64 Gynecologic Oncologists SGO 64 Medicine SIIM 64 Transcatheter Cardiovascular Therapeutics TCT 64 Endocrine Society Annual Meeting 64 Molecular Targets 64 Nephrology CJASN 64 Nephrology ASN 64 AACR Meeting 64 Clinical Chemistry AACC 64 Ophthalmology AAO 64 Breast Cancer Symposium SABCS 64 Rheumatology Annual 64 ORAL Sync 64 Diabetes EASD 64 AACR symposium 64 EASL 64 Prostate Cancer Symposium 64 Hyperthermic Oncology ESHO 64 AASLD 64 Breast Cancer Symposium 64 Gastrointestinal Endoscopy ASGE 64 Clinical Pathology ASCP 63 Malignant Lymphoma 63 Annual Transcatheter Cardiovascular 63 Minimally Invasive Cardiothoracic Surgery 63 Endocrine Society ENDO 63 CROI 63 SABCS 63 AAO HNSF Annual Meeting 63 Therapeutic Radiation Oncology 63 Antimicrobial Agents 63 Midyear Clinical Meeting 63 ASCO Breast Cancer 63 Clinical Trial Results 63 Interventions SCAI 63 UEGW 63 Clinical Microbiology 63 Symposium SABCS 63 Paediatric Oncology SIOP 63 Cardiology Scientific Sessions 63 ECCMID 63 ASTRO Annual Meeting 63 Gastroenterology ACG Annual 62 #nd EORTC NCI 62 Combination REOLYSIN R 62 Liver Diseases 62 & Immunology AAAAI 62 ASCO GU 62 TG MV 62 Liver Disease AASLD 62 Heart Failure Society 62 Annual ICAAC 62 AASLD Meeting 62 Transcatheter Cardiovascular Therapeutics 62 Toxicology SOT 62 Therapeutics TCT 62 International Cartilage Repair 62 European CanCer Organisation ECCO 62 Advanced Neuroendocrine Tumors 62 Bariatric Surgery ASBS 62 Cervical Pathology 62 ARVO 62 Thoracic Surgeons STS 62 Announces Poster Presentations 62 ASCO 62 Vascular Biology ATVB 61 Gastrointestinal Endoscopy 61 Brentuximab Vedotin SGN 61 Urology EAU 61 Immunology Annual Meeting 61 Ophthalmology ARVO 61 ECCO ESMO 61 Experimental Biology Annual Meeting 61 International Myeloma Workshop 61 Cystic Fibrosis Conference NACFC 61 Outcomes Research ISPOR 61 ASGT 61 dose escalation clinical 61 Cardiology Heart Failure 61 Thoracic Surgeons 61 Neck Surgery Foundation 61 AACR 61 Randomized Phase 61 Dermatologic Surgery ASDS 61 Clinical Trials Update 61 Cloretazine ® 61 ERA EDTA 61 Healthcare Epidemiology 61 Opportunistic Infections CROI 61 Poster Discussion 61 Canaccord Adams Hepatitis C 61 Neurology AAN Annual Meeting 61 Neurological Surgeons AANS 61 Transplantation AST 61 Alzheimer Disease ICAD 60 ENDO 60 AABB Annual Meeting 60 Ophthalmology Annual Meeting 60 Ocular Pharmacology 60 Vascular Annual Meeting 60 Gastroenterology ACG 60 Plastic Surgeons ASPS Plastic 60 NASDAQ CXSP announced 60 Pharmacoeconomics 60 BiTE R 60 International Papillomavirus 60 AACR IASLC Joint 60 PROVENGE sipuleucel T 60 American Thoracic Society 60 ASBMR 60 Hsp# Inhibitor 60 Applied Spectroscopy 60 Investigative Pathology 60 Remote Sensing ASPRS 60 ACR ARHP 60 Clinical Oncology JCO 60 Endoscopic Surgeons SAGES 60 Diabetologia 60 Haemostasis ISTH 60 Jupiter Tequesta Orchid 60 Cardiology ACC 60 Endocrine Society #nd 60 Annual Interscience Conference 60 #rd Annual CTRC 60 Addiction Medicine ASAM 60 Chicago Multidisciplinary Symposium 60 Colposcopy 60 SUCCEED trial 60 ESMO 60 Phase 2a clinical 60 BIOCOM Investor Conference 60 Immunodeficiencies 60 USpella 60 Endovascular Therapy ISET 59 International OARSI 59 metastatic castration resistant 59 Menopause Society NAMS 59 Chemotherapy ICAAC Infectious Diseases 59 Phase Ib study 59 Arch Surg 59 Gastrointestinal Cancer 59 Oak Brook Ill. RSNA.org 59 Lung Transplantation 59 Infectious Diseases ECCMID 59 San Antonio Breast Cancer 59 Transplant Surgeons ASTS 59 Movement Disorder 59 Venereology EADV 59 EULAR Annual 59 Hedgehog Pathway Inhibitor 59 Bariatric Physicians ASBP 59 phase IIb study 59 Related Disorders ICAD 59 Ophthalmology ARVO Annual Meeting 59 Endocrine Society #st 59 Rheumatology Annual Meeting 59 EuroPCR 59 Radiologic Technologists ASRT 59 Antimicrobial Chemotherapy 59 ASCO Gastrointestinal Cancers Symposium 59 Phase 2b Clinical Trial 59 Clinical Virology Symposium 59 ASCO abstract 59 American Gastrointestinal Endoscopic 59 Gynecological Oncologists 59 SCAI Annual 59 Pediatric Academic Societies PAS 59 Clinical Chemistry 59 PROSTVAC TM 59 Integrative Oncology 59 Investigative Dermatology 59 HCV SPRINT 59 Hand ASSH 59 registrational Phase 59 Neuropsychopharmacology 59 Rheumatology ACR 59 Oral Fingolimod 59 Phase 2b trial 59 Biologic Therapy 59 rALLy clinical trial 59 II Clinical Trial 59 www.aacr.org 59 Cardiovascular Computed Tomography 59 BRIM3 59 www.asco.org 59 Clinical Endocrinologists AACE 59 Phase Ib II 59 INSPIRE Trial Phase III 59 evaluating tivozanib 59 Cardiovascular Angiography 58 Association Executives ASAE 58 Phase III psoriasis 58 EVEREST II 58 Randomized Phase II 58 Targeted Anticancer Therapies 58 FOLOTYN ® 58 Neoplasia 58 America HFSA 58 Completes Patient Enrollment 58 ASMS Conference 58 CALGB # [002] 58 Br J Cancer 58 Roentgenology 58 BIO InvestorForum 58 Thoracic Surgery AATS 58 Paediatric Infectious Diseases 58 assessing T DM1 58 Selective Cardiac Myosin 58 & OTO EXPO 58 ENDEAVOR III 58 Epilepsy Society 58 recurrent malignant glioma 58 AIR2 Trial 58 Solorel TM 58 #th Interscience Conference 58 Proc Am Soc 58 Maternal Fetal Medicine SMFM 58 CRLX# 58 Phase III Clinical Trial 58 Phase 2a trial 58 Biomolecular Sciences SBS 58 Antiviral Research 58 Marine Mammalogy 58 Lysosomal Disease Network 58 Oncology Nursing 58 Presents Positive 58 non nucleoside inhibitor 58 ® DDW 58 alvespimycin 58 rALLy trial 58 Endovascular Therapy 58 Clinical Dermatology 58 GASTRO 58 Biodefense Vaccines 58 Healthcare Publication Editors 58 Female Urology 58 Cachexia 58 novel VDA molecule 58 Golf Course Architects ASGCA 58 Arch Neurol 58 Medicine AAPM 58 journal Antimicrobial Agents 58 Phase 1b trial 58 HIMSS Healthcare 58 Am J Epidemiol 58 entitled Synergistic 57 Plant Biologists ASPB 57 Amrubicin 57 Interventional Pain Physicians ASIPP 57 Pediatric Academic Society 57 Neuro Oncology 57 Aflibercept 57 Equine Practitioners Convention 57 histone deacetylase HDAC inhibitor 57 J Clin Oncol 57 HCV NS5B polymerase 57 Ocular Inflammation 57 Interventional Radiology 57 Opportunistic Infections 57 Oral Presentation 57 Cardiovascular Therapeutics 57 perifosine KRX 57 Nordic ACTI 57 RECORD1 57 ABCSG 57 Breaking Clinical Trials 57 NASDAQ CYTK announced 57 Pediatric Academic Societies 57 Pivotal Clinical Trial 57 Cell Transplant 57 Phase Ib clinical 57 Hygiene ASTMH 57 Neurological Surgeons Annual Meeting 57 Nuclear Cardiology 57 Oral Presentations 57 Heart Rhythm 57 Pediatric Otolaryngology 57 Tanespimycin 57 Refractive Surgery ASCRS 57 Adolescent Medicine SAM 57 mitogen activated ERK kinase 57 phase IIa 57 Vascular Surgery SVS 57 AVERROES 57 Information Display SID 57 including eniluracil ADH 57 Consultant Pharmacists ASCP 57 Reproductive Medicine specify 57 Interscience Conference 57 Exploration Geophysicists SEG 57 Gynecologic Cancer Society 57 Systemic Sclerosis 57 dose escalation trial 57 Poster Presentations 57 Spine Arthroplasty Society 57 Phase III ADT 57 Annual Meeting 57 Biomolecular Sciences 57 Developmental Therapeutics Immunotherapy 57 J Natl Cancer Inst 57 ENDEAVOR IV 57 Phase 2a Study 57 Human Brain Mapping 57 Rhinology 57 Phase III ALLEGRO 57 Chronic Lymphocytic Leukemia CLL 57 Phase #b/#a clinical 57 phase 2a 57 Environ Health Perspect 57 Atrial Fibrillation Symposium 57 Percutaneous Cardiovascular Interventions 57 number NCT# ClinicalTrials.gov 57 KRN# 57 System Pharmacists Midyear 57 MOZOBIL 57 Poster Presentation 57 Phase #/#a trial 57 sorafenib tablets 57 Presents Preclinical 57 FDA Oncologic Drugs 57 Spine Society 57 Paediatric Endocrinology 57 Urologic Oncology SUO 57 Minimally Invasive Gynecology 57 Aesthetic Plastic Surgery ISAPS 57 Ann Rheum Dis 57 Thoracic Oncology 57 BR.# 57 Dermatology AAD 57 Neurological Societies 57 antibody blinatumomab MT#/MEDI-# 57 EORTC 57 enzastaurin 57 phase IIb trial 57 TACI Ig 57 Bipolar Disorders 57 Randomized Phase III 57 Phase 2a Trial 57 Inc. Nasdaq OPTR 57 phase IIb clinical 56 ARVO Annual Meeting 56 CTAP# Capsules 56 Diabetic Macular Edema 56 Phase III placebo controlled 56 ACUITY trial 56 ExTRACT TIMI 56 PreCISe 56 ACR ARHP Annual 56 MEND CABG 56 Multiple Sclerosis ECTRIMS 56 Personalized Immunotherapy 56 ASH Abstract # 56 phase IIa clinical 56 Metastatic Melanoma 56 Diabet Med 56 Society Nephrology CJASN 56 axitinib 56 Gynecological Cancer 56 Cancer Immunotherapy 56 Preclinical Data 56 Heart Assn 56 Angiology 56 LymphoStat B TM 56 IL# PE#QQR 56 randomized discontinuation trial 56 BRIM2 56 Aesthetic Mesotherapy 56 SAEM Annual Meeting 56 Oncology ESTRO 56 ENESTnd 56 Molecular Medicine Tri 56 Anticancer Drug 56 Cardiovascular Computed Tomography SCCT 56 Management SCDM 56 Chronic Lymphocytic Leukemia 56 Global Healthcare Unplugged 56 huN# DM1 56 Inc. Nasdaq VRUS 56 metastatic hormone refractory 56 Nanomedicine ASNM 56 COU AA 56 Preclinical Study 56 PROactive Study 56 Natalizumab 56 Ophthalmic Drugs Advisory 56 oral ridaforolimus 56 BioCentury Future Leaders 56 abstracts summarizing 56 CYT# potent vascular disrupting 56 Delcath Phase III 56 VEITHsymposium 56 trastuzumab DM1 T DM1 56 IEEE Electron Devices 56 pralatrexate injection folate analogue 56 Anti Infective Drugs 56 Inc. Nasdaq IMGN 56 metaglidasen 56 CLARITY study 56 Gastrointestinal Oncology 56 PROTECT AF 56 Hormone Refractory Prostate Cancer 56 Br J Haematol 56 EOquin TM 56 J Clin Endocrinol Metab 56 Edge STudy 56 Malignant Mesothelioma 56 Interventional Radiology interventional radiologisiceberg lettuces 56 Molecular Pathology AMP 56 Retroviruses 56 comparing alemtuzumab 56 Orthopedic Surgeons AAOS 56 Chest Physicians CHEST 56 EMBO J. 56 Society HIMSS 56 Glufosfamide 56 forodesine 56 Abstract # 56 Carfilzomib 56 CUSTOM III 56 PEGylated interferon beta 1a 56 Annual AIFA 56 Clinical Virology 56 Am J Pathol 56 Rectal Surgeons 56 Therapeutics Roundtable 56 Phase 2a Clinical Trial 56 fosbretabulin 56 vascular disrupting agent 56 AACR Frontiers 56 CR# vcMMAE 56 Endourology 56 Hyperthermic Oncology 56 Meets Primary Endpoint 56 Arch Intern Med 56 Androxal TM 56 DIA Annual Meeting 56 ELACYT 56 Pirfenidone 56 PANVAC VF 56 International Neuropsychological Society 56 Safinamide 56 Intraoperative Surgical Planning 56 Phase 2b study 56 Abstract Accepted 56 Liver Disease 56 Allergology 56 Cardiovascular Interventions 56 Hematological Malignancies 56 randomized Phase III 56 interferon gamma 1b 56 oral rivaroxaban 56 Experimental NeuroTherapeutics 56 Ceflatonin R 56 Respiratory Society 56 midstage clinical 56 ThermoDox R 55 XL# SAR# 55 Rheumatology 55 multicenter Phase 55 refractory multiple myeloma 55 Liver Meeting 55 Abstract Number 55 Phase 2b 55 American Urological Association 55 HuMax CD4 55 Initiated Phase 55 CRMD# 55 randomized controlled Phase 55 AACR EORTC NCI 55 TASKi2 55 EFNS 55 huC# DM4 55 HFSA Annual 55 Inc. Nasdaq ATHX 55 Experimental Hematology 55 elotuzumab 55 Perifosine 55 Semafore Pharmaceuticals 55 R lenalidomide 55 Surgery ASLMS 55 SCCHN 55 CHEST 55 Gemzar ® 55 Orthopaedic Surgeons Annual Meeting 55 Phase III AFFIRM 55 recurrent glioma 55 Drugs Affecting Lipid 55 DDW ® 55 anticancer compound 55 Vacuum Coaters 55 CombAT 55 resistant hormone refractory 55 GVAX ® 55 Medical Oncology 55 acute PAO 55 Biomolecular Screening 55 relapsed refractory multiple myeloma 55 novel histone deacetylase 55 Society Nephrology JASN 55 Experimental Biology EB 55 Cardiovascular Magnetic Resonance 55 orally inhaled migraine 55 NASDAQ SLXP today 55 delafloxacin 55 CLL8 55 Castration Resistant Prostate Cancer 55 Geochimica et Cosmochimica Acta 55 Nuclear Cardiology ASNC 55 America RSNA 55 placebo controlled clinical 55 FOLFOX6 chemotherapy regimen 55 Nutrition ASN 55 Minimally Invasive Spine Surgery 55 mGluR5 negative 55 Investor Luncheon 55 Hepatology journal 55 Molecular Cancer 55 taxane resistant 55 Physiology Endocrinology 55 NASDAQ PCYC 55 Healthcare Engineering ASHE 55 AAPS Annual Meeting 55 fidaxomicin Phase 3 55 oral proteasome inhibitor 55 Inflammatory Arthritis 55 Microplasmin 55 evaluating mipomersen 55 Epileptology 55 TXPO 55 HORIZONS AMI trial 55 RGB # 55 ISTH 55 Zenvia Phase III 55 Psychiatry #:#-# [003] 55 Vaccine Adjuvant 55 Advanced Renal Cell 55 YONDELIS 55 Reports Preclinical Data 55 Pooled Analysis 55 Presents Preclinical Data 55 Augment Injectable 55 Immunologists 55 Obes Res 55 Phase 2b Trial 55 neratinib 55 Related Viruses 55 Research IADR 55 Anticancer Drugs 55 Vaccine Immunology 55 Phase 2a 55 Ann Intern Med 55 Intensive Care Medicine 55 Selective Cardiac Myosin Activator 55 Clin Chem 55 ZYBRESTAT 55 Gastroenterology Nurses 55 Active Biotech NASDAQ OMX 55 Plastic Surgeons ASPS 55 lexidronam injection 55 Echocardiography 55 Announces Presentation 55 Aryplase 55 Annual Institutional Investor 55 sulodexide 55 PERSEUS 55 Endovascular Valve Edge 55 Hair Restoration Surgery 55 Lung Cancer IASLC 55 Pivotal Trial 55 Arch Pediatr Adolesc Med 55 Double Blind Placebo 55 COPIC Energy 55 Pulmonary Arterial Hypertension 55 PRNewswire FirstCall Genaera 55 R roscovitine 55 PEG SN# 55 Dermatological Surgery 55 lorvotuzumab mertansine 55 Oncologic Drugs Advisory 55 HDL Selective Delipidation 55 PRNewswire FirstCall Tercica 55 Dermatology Physician Assistants 55 Radiology Imaging Network ACRIN 55 Nasdaq CYCC Nasdaq CYCCP 55 SAWC WHS 55 Phase 1a clinical 55 essential thrombocythemia ET 55 Postgraduate Course 55 PROSTVAC VF 55 Xcytrin R 55 maximally tolerated dose 55 Overactive Bladder OAB 55 LymphoStat B 54 ARRY # 54 ABRF 54 DASISION 54 Neurochemistry 54 Nasdaq ENZN 54 preclinical efficacy 54 website www.asco.org 54 metastatic HRPC 54 ANN INTERN MED 54 HCV RESPOND 2 54 ThermoDox ® clinical 54 Traficet EN 54 LibiGel ® 54 Phase #/#a 54 oral prodrug 54 relapsed multiple myeloma 54 NO# [002] 54 phase Ib 54 cetuximab Erbitux 54 Metabolic Disorders 54 Cimzia ® certolizumab pegol 54 ASCRS 54 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 54 #:#-# [007] 54 Romiplostim 54 Aesthetic Plastic Surgery ASAPS 54 ASCO Prostate Cancer 54 HQK 54 Urocortin 2 54 cisplatin gemcitabine 54 HoFH 54 Plastics Engineers SPE 54 MERIT ES 54 Inc. Nasdaq AVRX 54 Inc. NASDAQ HEPH 54 CTRC AACR 54 Recurrent Chest Wall 54 AAAAI Annual Meeting 54 oral FTY# 54 Ambrisentan 54 Bariatric Surgeons 54 phase IIb 54 PROSTASCINT R 54 Immunology AAAAI 54 Nasdaq GNTA 54 PRNewswire FirstCall Amylin Pharmaceuticals 54 Elagolix 54 Therapeutic Targets 54 Gynecologic Laparoscopists 54 JAK2 Inhibitor 54 LUX Lung 54 Archexin 54 multicenter Phase II 54 mg administered orally 54 Experimental Biology FASEB 54 ILLUMINATE 54 Nasdaq IDRA today 54 sorafenib Nexavar 54 Pediatric Oncology Branch 54 antibody MT# 54 PSN# [002] 54 HORIZONS AMI 54 NYSE Amex RGN 54 Thromb Haemost 54 EUROGIN 54 INCB# [001] 54 www.hematology.org 54 vidofludimus 54 Medicine ISMRM 54 th Interscience Conference 54 Severe Sepsis 54 Travel Writers SATW 54 Cancer Therapeutic 54 chemotherapy gemcitabine 54 Hematological 54 Veterinary Dental 54 Canaccord Genuity Musculoskeletal 54 Ovarian PLCO Cancer 54 PNP inhibitor 54 Molecular Origins 54 Cutaneous T 54 Inc. Nasdaq BIOD 54 Phase Ib Clinical Trial 54 Ophthalmic Plastic 54 NCCN Clinical Practice 54 CIMZIA TM certolizumab pegol 54 Experimental Biology 54 SPIRIT III 54 American Psychosomatic Society 54 Prostate AdenoCarcinoma Treatment 54 SPIRIT IV 54 resistant ovarian cancer 54 #:# -# [004] 54 PRNewswire FirstCall Genta Incorporated 54 omacetaxine mepesuccinate 54 HCV Protease Inhibitor 54 Tumor Biology 54 Pain Medicine AAPM 54 AAG geldanamycin analog 54 Annual BIO 54 www.delcath.com 54 Nasdaq SNSS 54 liposome injection 54 Physiology Regulatory Integrative 54 Phase 1b clinical trials 54 Inc. Nasdaq CRTX 54 depsipeptide 54 HCV polymerase inhibitors 54 Cancer EORTC 54 journal Arteriosclerosis Thrombosis 54 #:#-# [031] 54 Nephrol Dial Transplant 54 Liver Physiology 54 Randomized Study 54 Professional Engineers NSPE 54 iSBTc 54 RANK Ligand inhibitor 54 CCX# 54 EXPAREL ™ 54 www.nejm.org 54 Phase 1b 54 briakinumab 54 Artificial Organs 54 Chest Pain Centers SCPC 54 Retrovirus Conference 54 Bone Marrow Transplantation 54 Podium Presentation 54 Printable slides 54 Preclinical Efficacy 54 Neuropsychopharmacology ACNP 54 Tolvaptan 54 CALGB 54 oral JAK1 54 CUSTOM II 54 journal Menopause 54 Free Full Text 54 Canaccord Adams Musculoskeletal 54 AA Amyloidosis 54 Randomized Double blind 54 RhuDex R 54 Belimumab 54 ISHLT 54 Clinical Densitometry 54 EULAR 54 J Am Coll 54 Maxillofacial Surgeons 54 CANCER peer reviewed 54 Anaesthesiologists 54 RNAi Therapeutic 54 Inflammatory Bowel Diseases 54 pharmacokinetic PK study 54 Poster Session 54 Multicenter 54 Clinical Psychopharmacology 54 www.durect.com 54 relapsing remitting MS RRMS 54 Ann Oncol 54 PERSEUS clinical program 54 Photo Optical Instrumentation 54 Ambulatory Anesthesia 54 Aplidin R 54 Plicera 54 CEQ# 54 Endocrine Practice 54 REG2 54 Neurological Surgeons 54 Initiates Clinical Trial 54 Craig Hallum Institutional Investor 54 Acute Heart Failure 54 Stent Thrombosis 54 Phase Ib clinical trials 54 Prolongs Survival 53 LibiGel testosterone gel 53 mCRC patients 53 Thrombosis 53 Nasdaq PCYC 53 NAREIT Investor 53 Triapine R 53 bazedoxifene conjugated estrogens 53 Talabostat 53 ganetespib 53 Dendritic Cells 53 LBH# 53 seliciclib CYC# 53 novel trazodone formulation 53 E CENP E 53 FASEB J. 53 Eur Respir J 53 CTI Nasdaq 53 Cellular Therapy 53 Phase IIB clinical 53 NSTI Nanotech 53 Interventional Radiologists 53 phase IIIb 53 ToGA 53 EURIDIS 53 Agronomy ASA 53 ACC.# 53 AAPOS 53 evaluating REVLIMID 53 IRX 2 53 Nexavar sorafenib 53 HuMax EGFr 53 randomized multicenter trial 53 entinostat 53 ADVANCE PD 53 Preventive Oncology 53 Zarnestra 53 Remote Sensing ISPRS 53 recurrent GBM 53 Investigational Drug 53 ON #.Na 53 Late Deafened Adults 53 PRNewswire FirstCall Ardea Biosciences 53 Nasdaq REGN 53 Dacogen injection 53 Nephrology 53 NCIC CTG 53 Antiviral Drugs Advisory 53 Acute Decompensated Heart Failure 53 APPRAISE 53 Inc. Nasdaq RDYN 53 Gynecologic Oncology Group 53 MTT S 53 General Psychiatry #:#-#,# 53 Urologic Oncology 53 Autoimmune Diseases 53 Genta Incorporated OTCBB GETA 53 Interventional Pain Physicians 53 Panzem R 53 Optical Engineering 53 Cardiostim 53 Sipuleucel T 53 PSMA ADC 53 HIV Pathogenesis 53 alvimopan 53 Int J Epidemiol 53 BCIRG 53 Mammalogists 53 trabectedin 53 plus Copegus R 53 ALN TTR 53 abstr 53 Pediatric Radiology 53 prospective multicenter 53 pertuzumab 53 EACTS 53 #:# -# [006] 53 Critical Care Medicine 53 Nasdaq NPSP 53 Cardiovascular Disease Epidemiology 53 Physiology Renal Physiology 53 brivaracetam 53 Bariatric Surgery ASMBS 53 galiximab 53 zanolimumab 53 Regional Anesthesia 53 AEG# 53 randomized Phase IIb 53 Zybrestat 53 multicenter clinical 53 Needham Biotechnology 53 Solid Tumors 53 J Clin Invest 53 Intervention Effectiveness 53 sunitinib Sutent 53 resolvin 53 Pemetrexed 53 LSE ASM 53 Neuromodulation Society 53 BioNumerik 53 Inc. NASDAQ AGIX 53 Prospective Randomized 53 NCCTG N# 53 Kinase Inhibitor 53 Bortezomib 53 Xelox 53 dasatinib Sprycel 53 RIO Lipids 53 Radiation Oncology Biology 53 TAXUS Element Paclitaxel Eluting 53 SPIRIT FIRST 53 Inc. NASDAQ NBIX 53 TRANSFORMS 53 Targeted Therapies 53 Neuropathic Pain 53 EASD 53 metastatic renal cell carcinoma 53 Nasdaq IMGN 53 PFO migraine 53 radezolid 53 Urologic 53 CLARITY TIMI 53 ZYBRESTAT fosbretabulin 53 coronary stent merged 53 rivaroxaban Xarelto 53 Inc. Nasdaq AMLN 53 Nat Med 53 Nat Genet 53 HepaSphere

Back to home page